Loading organizations...
Key people at Innovation Growth Ventures.
Innovation Growth Ventures functions as a specialized venture capital fund manager, primarily overseeing the Innovation Growth Fund (IGF). It actively identifies and invests in transformational, technology-driven companies that are poised to shape the future across diverse sectors. Their strategic approach involves cultivating new ideas and promising innovations, focusing on areas such as entertainment, FinTech, enterprise SaaS, DeepTech, and ClimateTech.
The genesis of Innovation Growth Ventures traces back to the joint establishment of the Innovation Growth Fund by Sony Group Corporation and Daiwa Investment Management, Inc. This collaboration was born from a shared insight: to combine Sony's extensive legacy of innovation and creativity with Daiwa's financial acumen. The goal was to strategically deploy capital into mid- to late-stage startups, fostering their development through robust corporate backing and expert fund management.
Innovation Growth Ventures’ primary beneficiaries are the startups they invest in, which are bringing new forms of technology to global markets. The firm’s overarching vision is to drive deeper engagements with these emerging companies, acting as a critical bridge to Sony's global network, technical expertise, and business resources. This enables supported companies to scale, ultimately contributing to meaningful societal, environmental, and financial advancements.
Key people at Innovation Growth Ventures.
Innovation Growth Ventures has 1 tracked investment across 1 company. The latest tracked deal is $40.0M Series B in Exo in August 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 1, 2020 | Exo | $40.0M Series B | Action Potential Venture Capital, Fiscus Ventures, TED Koutouzis MD | Energy Impact Partners, Applied Ventures, Bold Capital, Creative Ventures, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Solasta Ventures, Anil Achyuta, Wanxiang Healthcare Investments |